138 related articles for article (PubMed ID: 16868537)
1. Receptor targeting agents for imaging inflammation/infection: where are we now?
Signore A; Chianelli M; D'Alessandria C; Annovazzi A
Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):236-42. PubMed ID: 16868537
[TBL] [Abstract][Full Text] [Related]
2. Radiolabelled probes targeting infection and inflammation for personalized medicine.
Signore A; Lauri C; Galli F
Curr Pharm Des; 2014; 20(14):2338-45. PubMed ID: 24025100
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging.
Kumar V
Q J Nucl Med Mol Imaging; 2005 Dec; 49(4):325-38. PubMed ID: 16407816
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview.
Okarvi SM
Nucl Med Commun; 1999 Dec; 20(12):1093-112. PubMed ID: 10664991
[TBL] [Abstract][Full Text] [Related]
5. Imaging of infection and inflammation with 18F-FDG-labeled leukocytes.
Rini JN; Palestro CJ
Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):143-6. PubMed ID: 16770304
[TBL] [Abstract][Full Text] [Related]
6. SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
Anzola LK; Galli F; Dierckx RA
Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):197-213. PubMed ID: 25669765
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.
van Eerd JE; Boerman OC; Corstens FH; Oyen WJ
Q J Nucl Med; 2003 Dec; 47(4):246-55. PubMed ID: 14973417
[TBL] [Abstract][Full Text] [Related]
8. [The role of 99mTc-ciprofloxacin scan in infection imaging].
Markou P; Spyridonidis T
Hell J Nucl Med; 2005; 8(2):74-80. PubMed ID: 16142247
[TBL] [Abstract][Full Text] [Related]
9. Isotopic biomarker discovery and application in translational medicine.
Bayele HK; Chiti A; Colina R; Fernandes O; Khan B; Krishnamoorthy R; Ozdağ H; Padua RA
Drug Discov Today; 2010 Feb; 15(3-4):127-36. PubMed ID: 20038454
[TBL] [Abstract][Full Text] [Related]
10. Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery.
Rijpkema M; Boerman OC; Oyen WJ
Curr Drug Targets; 2015; 16(6):625-33. PubMed ID: 25355181
[TBL] [Abstract][Full Text] [Related]
11. Imaging of infection and inflammation with 99mTc-Fanolesomab.
Love C; Tronco GG; Palestro CJ
Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):113-20. PubMed ID: 16770301
[TBL] [Abstract][Full Text] [Related]
12. Non-oncologic applications of radiolabeled peptides in nuclear medicine.
Knight LC
Q J Nucl Med; 2003 Dec; 47(4):279-91. PubMed ID: 14973420
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceuticals for the study of inflammatory processes: a review.
Chianelli M; Mather SJ; Martin-Comin J; Signore A
Nucl Med Commun; 1997 May; 18(5):437-55. PubMed ID: 9194086
[TBL] [Abstract][Full Text] [Related]
14. Development of specific radiopharmaceuticals for infection imaging by targeting infectious micro-organisms.
Ferro-Flores G; Ocampo-Garcia BE; Melendez-Alafort L
Curr Pharm Des; 2012; 18(8):1098-106. PubMed ID: 22272827
[TBL] [Abstract][Full Text] [Related]
15. Nuclear medicine applications in molecular imaging: 2007 update.
Blankenberg FG; Strauss HW
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):99-110. PubMed ID: 17420712
[TBL] [Abstract][Full Text] [Related]
16. Reporter gene imaging: potential impact on therapy.
Serganova I; Blasberg R
Nucl Med Biol; 2005 Oct; 32(7):763-80. PubMed ID: 16243653
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET for imaging of non-osseous infection and inflammation.
Vos FJ; Bleeker-Rovers CP; Corstens FH; Kullberg BJ; Oyen WJ
Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):121-30. PubMed ID: 16770302
[TBL] [Abstract][Full Text] [Related]
18. The radiopharmaceutical chemistry of 99mTc-tin fluoride colloid-labeled-leukocytes.
Tsopelas C
Q J Nucl Med Mol Imaging; 2005 Dec; 49(4):319-24. PubMed ID: 16407815
[TBL] [Abstract][Full Text] [Related]
19. [Differential indications for various radioactive medications for several inflammatory diseases].
Becker W
Nuklearmedizin; 1999; 38(6A):243. PubMed ID: 10510819
[No Abstract] [Full Text] [Related]
20. [Guidelines for Tc-99m-HMPAO leukocyte scintigraphy in inflammatory or infectious diseases].
Becker W
Nuklearmedizin; 1999; 38(6A):240-2. PubMed ID: 10510818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
